
Andrew P. Lee
Examiner (ID: 15977)
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1628, 1629, 1691, 1621 |
| Total Applications | 704 |
| Issued Applications | 285 |
| Pending Applications | 97 |
| Abandoned Applications | 333 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11554105
[patent_doc_number] => 20170100351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/342783
[patent_app_country] => US
[patent_app_date] => 2016-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23374
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15342783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/342783 | EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF | Nov 2, 2016 | Abandoned |
Array
(
[id] => 11542566
[patent_doc_number] => 20170096391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'NOVEL LACTAMS'
[patent_app_type] => utility
[patent_app_number] => 15/335926
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11048
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15335926
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/335926 | NOVEL LACTAMS | Oct 26, 2016 | Abandoned |
Array
(
[id] => 13507655
[patent_doc_number] => 20180305370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => ETHYLENE GLYCOL ETHER OF BUPRENORPHINE
[patent_app_type] => utility
[patent_app_number] => 15/767320
[patent_app_country] => US
[patent_app_date] => 2016-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767320
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767320 | ETHYLENE GLYCOL ETHER OF BUPRENORPHINE | Oct 24, 2016 | Abandoned |
Array
(
[id] => 11618274
[patent_doc_number] => 20170128462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'METHODS FOR TREATING FEMALE SEXUAL DYSFUNCTION WHILE DECREASING CARDIOVASCULAR RISK'
[patent_app_type] => utility
[patent_app_number] => 15/331360
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6849
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331360
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/331360 | METHODS FOR TREATING FEMALE SEXUAL DYSFUNCTION WHILE DECREASING CARDIOVASCULAR RISK | Oct 20, 2016 | Abandoned |
Array
(
[id] => 18353972
[patent_doc_number] => 11642356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 16/343690
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9944
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343690 | Pharmaceutical compositions | Oct 20, 2016 | Issued |
Array
(
[id] => 14563831
[patent_doc_number] => 20190209522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => HIGH-DOSE STATINS FOR AGE-RELATED MACULAR DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 15/768367
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768367
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/768367 | High-dose statins for age-related macular degeneration | Oct 13, 2016 | Issued |
Array
(
[id] => 13489863
[patent_doc_number] => 20180296474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RETINAL CAPILLARY NON-PERFUSION
[patent_app_type] => utility
[patent_app_number] => 15/765854
[patent_app_country] => US
[patent_app_date] => 2016-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15765854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/765854 | Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion | Oct 11, 2016 | Issued |
Array
(
[id] => 11554102
[patent_doc_number] => 20170100348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'Treatment Regime for Chronic Sinusitis'
[patent_app_type] => utility
[patent_app_number] => 15/291787
[patent_app_country] => US
[patent_app_date] => 2016-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4373
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15291787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/291787 | Treatment Regime for Chronic Sinusitis | Oct 11, 2016 | Abandoned |
Array
(
[id] => 13476279
[patent_doc_number] => 20180289682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => COMPOUNDS AND METHODS FOR PROMOTING STRESS RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 15/766797
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766797
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766797 | Compounds and methods for promoting stress resistance | Oct 6, 2016 | Issued |
Array
(
[id] => 11935114
[patent_doc_number] => 20170239263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'METHOD OF WEIGHT MANAGEMENT'
[patent_app_type] => utility
[patent_app_number] => 15/287019
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21832
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287019
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287019 | METHOD OF WEIGHT MANAGEMENT | Oct 5, 2016 | Abandoned |
Array
(
[id] => 12603369
[patent_doc_number] => 20180092953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => MEDICAL CANNABIS RECOMMENDATION
[patent_app_type] => utility
[patent_app_number] => 15/283386
[patent_app_country] => US
[patent_app_date] => 2016-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15283386
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/283386 | MEDICAL CANNABIS RECOMMENDATION | Sep 30, 2016 | Abandoned |
Array
(
[id] => 12383016
[patent_doc_number] => 09961903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Biocidal compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/276824
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2133
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/276824 | Biocidal compositions and methods of use | Sep 26, 2016 | Issued |
Array
(
[id] => 11526483
[patent_doc_number] => 20170086461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'SYNERGISTIC ANTIMICROBIAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/277485
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1492
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15277485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/277485 | SYNERGISTIC ANTIMICROBIAL COMPOSITION | Sep 26, 2016 | Abandoned |
Array
(
[id] => 13489979
[patent_doc_number] => 20180296532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => RNA-Focused Small Molecules for Inhibiting RNA Toxicity in Myotonic Dystrophy
[patent_app_type] => utility
[patent_app_number] => 15/760526
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760526
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760526 | RNA-Focused Small Molecules for Inhibiting RNA Toxicity in Myotonic Dystrophy | Sep 15, 2016 | Abandoned |
Array
(
[id] => 11499584
[patent_doc_number] => 20170073770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'METHOD FOR SUPPORTING DIAGNOSIS OF RISK OF COLORECTAL CANCER RECURRENCE, TREATMENT OF COLORECTAL CANCER, AND ADMINISTRATION OF ANTICANCER DRUG'
[patent_app_type] => utility
[patent_app_number] => 15/266385
[patent_app_country] => US
[patent_app_date] => 2016-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15769
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15266385
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/266385 | Method for supporting diagnosis of risk of colorectal cancer recurrence, treatment of colorectal cancer, and administration of anticancer drug | Sep 14, 2016 | Issued |
Array
(
[id] => 13397413
[patent_doc_number] => 20180250249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => METHODS OF TREATING NEURODEGENERATIVE DISORDERS IN A PARTICULAR POPULATION
[patent_app_type] => utility
[patent_app_number] => 15/758405
[patent_app_country] => US
[patent_app_date] => 2014-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758405
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758405 | Methods of treating neurodegenerative disorders in a particular population | Sep 8, 2016 | Issued |
Array
(
[id] => 13397541
[patent_doc_number] => 20180250313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => COMPOUNDS AND FORMULATIONS FOR TREATING OPHTHALMIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/758705
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758705
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758705 | COMPOUNDS AND FORMULATIONS FOR TREATING OPHTHALMIC DISEASES | Sep 7, 2016 | Abandoned |
Array
(
[id] => 11364223
[patent_doc_number] => 20170002204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'PROCESS TO PREPARE SURFACE-MODIFIED MINERAL MATERIAL, RESULTING PRODUCTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/259733
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7746
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15259733
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/259733 | PROCESS TO PREPARE SURFACE-MODIFIED MINERAL MATERIAL, RESULTING PRODUCTS AND USES THEREOF | Sep 7, 2016 | Abandoned |
Array
(
[id] => 13507569
[patent_doc_number] => 20180305327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => SUBSTITUTED DIHYDROBENZOFURAN COMPOUNDS AND THEIR USE AS SYNERGISTS
[patent_app_type] => utility
[patent_app_number] => 15/758771
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758771
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758771 | Substituted dihydrobenzofuran compounds and their use as synergists | Sep 6, 2016 | Issued |
Array
(
[id] => 13368657
[patent_doc_number] => 20180235869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => METHODS AND COMPOSITIONS FOR SOFT ANTICHOLINERGIC ZWITTERIONS
[patent_app_type] => utility
[patent_app_number] => 15/758153
[patent_app_country] => US
[patent_app_date] => 2016-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758153
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758153 | METHODS AND COMPOSITIONS FOR SOFT ANTICHOLINERGIC ZWITTERIONS | Sep 5, 2016 | Abandoned |